Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Mankind Pharma Q2 Review: Jefferies, Kotak Retain Buy After Strong Earnings. Check Target Prices

    1 day ago

    Jefferies maintained its Buy' rating on Mankind Pharma but lowered its target price to Rs 2,900 from Rs 3,220, citing a stronger growth outlook and easing integration challenges.
    Click here to Read More
    Previous Article
    Urban Company: Motilal Oswal Upgrades Rating To 'Buy' As Core Business Gains Momentum; Check Target Price
    Next Article
    Caught On Camera: 'Well Of Death' Stunt Goes Wrong; Woman Rider Suffers Burn Injuries As Bike Catches Fire

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment